Overview

Single Dose Pharmacokinetics of Prucalopride in Paediatric Subjects, With Functional Faecal Retention

Status:
Completed
Trial end date:
1999-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is characterize the pharmacokinetics of a single oral dose of 0.03 mg/kg prucalopride in paediatric subjects aged >= 4 to <= 12 years with functional faecal retention. Hypothesis: Pharmacokinetic profile of prucalopride in paediatric subjects is expected to resemble the adult pharmacokinetic profile
Phase:
Phase 1
Details
Lead Sponsor:
Movetis
Treatments:
Prucalopride